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ABSTRACT 
Objective: Chlorophyllin (CHL) belongs to a group of compounds, porphyrins that contain a chelated metal ion in the center of the molecule. The 
objective of this present study was to extract the Chlorophyllin from Mimosa pudica and to study its antimicrobial activity. 
Methods: The antimicrobial activity of chlorophyllin from the leaf extract of Mimosa pudica L., was determined in vitro, using well diffusion method 
against human pathogenic bacteria and fungi, viz., two Gram-negative bacteria: Pseudomonas aeruginosa and Escherichia coli, and two Gram-positive 
bacteria: Staphylococcus aureus and Klebsiella pneomoniae, and one fungal pathogen, Candida albicans.  
Results: Chlorophyllin from the leaf extract of Mimosa pudica recorded potential antimicrobial activity against the tested microorganism with the 
range of 9 mm-18 mm at 25-100 μg/ml. 
Conclusion: Natural Chlorophyllin from Mimosa pudica has significant activity against the five pathogenic test microorganisms.  
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Many of the modern medicines are produced indirectly from 
medicinal plants. Plants are directly used as medicines by a majority 
of cultures around the world for example, Chinese medicine and 
Indian medicine. Mimosa pudica Linn. (Mimosaceae) commonly 
known as the ‘sensitive plant’ is diffuse under a shrub. It is native to 
America but has naturalized throughout India [1]. The plant is well-
known for its medicinal properties particularly for the treatment of 
piles [2]. It has been traditionally used in the treatment of various 
ailments including alopecia, diarrhea, dysentery, insomnia, tumor, 
and various urogenital infections [3-5]. The present study was done to 
determine the antimicrobial activity of Chlorophyllin from Mimosa 
pudica. Chlorophyllin is semi-synthetic water soluble sodium copper salt 
of chlorophyll. During the synthesis of chlorophyllin the magnesium 
atom at the center of the ring is replaced with copper and the phytol tail 
is lost. Unlike natural chlorophyll, chlorophyllin is water-soluble [6]. The 
antioxidant property of CHL from Mimosa pudica was proved by the 
spectrophotometric method by the formation of Phospho-molybdenum 
complex [7]. We designed the present work to determine the 
antimicrobial activity of chlorophyllin extracted from Mimosa pudica. 
Mimosa pudica plant leaves were collected from Vels University campus, 
Pallavaram, Chennai. 
The plant was authenticated by Prof. P. Jayaraman, National Institute 
of Herbal Sciences. Ten grams of fresh leaves were taken and 1 gm of 
sodium carbonate was added to neutralize the acidity. The plant 
material was ground with 50–100 ml acetone and filtered using 
filter paper. This procedure is repeated until the residue becomes 
colorless. It was then washed with 50–150 ml of diethyl ether to 
wash off acetone. The mixture was poured into a separating funnel 
and acetone was washed off using distilled water. This was repeated 
until yellow color separates off which consists of flavones. The solution 
was poured into a bottle and 10–25 ml of methanol saturated with 
potassium hydroxide pellets was added. The solution was shaken 
thoroughly and kept in the icebox for overnight. The alkaline solution 
of chlorophyllin was poured into a separating funnel, and 100 ml 
diethyl ether was added and left for 30 min. Chlorophyllin separates 
off greenish layer which was removed. The ether layer was washed off 
with dilute potassium hydroxide and distilled water, to remove traces 
of chlorophyllin salts. The filtrate was evaporated to dryness in a 
rotary evaporator, and the extract was stored in ice box [8]. 
Two Gram-negative Pseudomonas aeruginosa and Escherichia coli 
and two Gram-positive Staphylococcus aureus and Klebsiella 
pneomoniae bacterial pathogens and one fungal pathogen Candida 
albicans were used for in vitro antimicrobial activity. They were 
obtained from MTCC (IMTECH, Chandigarh, India). The antibacterial 
activity was determined by well diffusion methods [9]. About 25 ml 
of molten Mueller Hinton agar and potato dextrose agar were 
poured into a sterile Petri plate (Himedia, Mumbai, India). The plates 
were allowed to solidify after which 18 h grown (OD adjusted to 0.6) 
100 µl of above said pathogenic cultures were transferred onto a 
plate and made culture lawn by using sterile L-rod spreader. After 
five minutes a sterile cork borer was used to make 5 mm well on the 
agar. The test samples were dissolved in methanol and loaded in to 
wells with various concentrations such as 25, 50, 75 and 100 μg/ml. 
Triplicates were maintained and the experiment was repeated thrice 
for each replicates the readings were taken in three different fixed 
directions and the average values were recorded. The streptomycin 
and Nystati (10μg/ml) added well served as positive control. The 
plates were incubated at 37 °C in a 40 W fluorescent light source (~ 
400 nm) for 24 h for bacterial pathogen and 48 h for the fungal 
pathogen. The antimicrobial activity was determined by measuring 
the diameter of the zone of inhibition around the well using 
antibiotic zone scale (Himedia, Mumbai, India). 
 
Table 1: Zone of the Inhibition of Standard Chlorophyllin for antimicrobial activity 
Name of the organisms Zone of the Inhibition (mm)  Streptomycin Sulphate  Nystatin  
Concentration(μg/ml) 25  50 75 100  10 10 
Staphylococcus aureus 11±0.33 12±0.66 13±0.57 14±0.57 16±0.33 19±0.33 
Pseudomonas aeruginosa 10±1.20 12±0.16 14±0.66 16±0.57 18±0.33 16±0.33 
Klebsiella pneumoniae 12±0.57 14±0.23 16±0.57 17±0.51 14±0.33 14±0.57 
Escherichia coli 14±0.23 15±0.66 16±0.42 18±0.88 15±0.33 16±0.33 
Candida albicans 11±0.57 13±0.79 14±0.33 16±0.57 16±0.33 18±0.57 
Values are mean of three independent replicates ± standard deviation 
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Table 2: Zone of the Inhibition of Mimosa pudica Chlorophyllin for antimicrobial activity 
Name of the organisms  Zone of the Inhibition (mm)  Streptomycin Sulphate Nystatin  
Concentration(μg/ml)  25  50  75  100 10 10 
Staphylococcus aureus  12±0.89 14±0.33  16±0.33  18±0.88  14±0.33 16±0.33 
Pseudomonas aeruginosa   8±0.33 11±0.66 12±1.20  13±0.57  12±0.33 12±0.11 
Klebsiella pneumoniae  14±0.57  16±0.33  18±0.33  19±0.79  11±0.33 14±0.57 
Escherichia coli  13±0.57  14±0.57  16±0.33  18±0.57  13±0.33 16±0.33 
Candida albicans  9±0.33 10±0.33  12±0.66 13±0.65  14±0.33 14±0.89 
Values are mean of three independent replicates ± standard deviations 
 
The result obtained in the present study revealed that chlorophyllin 
from Mimosa pudica possesses potential antimicrobial activity 
against Pseudomonas aeruginosa, Escherichia coli, Staphylococcus 
aureus, Klebsiella pneomoniae, and Candida albicans. The test 
material was effectively inhibited all test pathogens at all the tested 
concentrations. The lowest concentration of 25μg/mlshowed 
showed a zone of inhibition against all the tested pathogen were 
ranged between 6 mm and 15 mm whilst, the highest concentration 
of 100μg/ml 
Chlorophyllin from Mimosa pudica showed almost similar 
antibacterial activity against Staphylococcus aureus and Klebsiella 
pneumoniae is (12 mm-18 mm) and (14 mm-19 mm) at the 
concentration of 25-100 μg/ml). It shows almost similar or higher 
antibacterial activity in Pseudomonas aeruginosa followed by E. coli. 
Chlorophyllin standard showed almost similar or higher zone of 
inhibition in the entire five test organism (table 1). Antibacterial 
activity in standard chlorophyllin and chlorophyllin from Mimosa 
pudica were almost similar. The least activity was observed in 
Pseudomonas aeruginosa (10 mm) and the highest inhibitory activity 
was observed in Klebsiella pneumonia (18 mm). Zone of inhibition 
was almost similar or lower when compared with the streptomycin 
sulphate. Standard Chlorophyllin recorded better antifungal activity 
than Chlorophyllin from Mimosa pudica (table 2). Both showed less 
antifungal activity when compared with Nystatin. 
showed zone of inhibition ranged between 13 mm and 
23 mm (table 1&2). 
Medicinal plants are an important source for the development of 
new chemotherapeutic agents [10]. Many reports are available on 
the antibacterial, antifungal, antiviral and anti-inflammatory 
properties of medicinal plants [11-14], and there are many reports 
on antimicrobial activity of M. pudica whole plant but this is the first 
report on antimicrobial activity of Chlorophyllin extracted from the 
leaf of Mimosa pudica L. There were many reports available on 
antimicrobial activity from leaf extract, aqueous extract of stem 
bark, methanolic extract of leaves, and seed of Mimosa pudica (15-
17). The uses of the whole plant of Mimosa pudica was proven for 
various pharmacological and biological activities. Mostly Root and 
leaves of Mimosa pudica are showed maximum pharmacological 
activity [18]. In the present study antimicrobial activity of Mimosa 
was studied using well diffusion method at the concentration of 25-
100 μg/ml against the microbe.  
The result of this study revealed that the M. pudica leaf extract and 
standard chlorophyllin possesses inhibitory activity against the test 
pathogen used for screening, similar study was reported by 
Pawaskar against whole plant extract of Mimosa pudica against E. 
coli, Staphylococcus aureus, Staphylococcus albus, Proteus vulgaris, 
Salmonella typhi, Salmonella paratyphi A, Salmonella paratyphi B, 
Shigella flexneri, Klebsiella pneumonia, and pseudomonas aeruginosa. 
The Mimosa pudica whole plant extract possesses good 
antimicrobial activity between 7 mm-18 mm [19]. The present study 
reveals that both CHL and whole plant extract [19, 20] from Mimosa 
pudica have antimicrobial property. Mukesh Chandra Sharma et al. 
reported the antimicrobial activity against the crude extracts of 
Mimosa pudica Linn using six different solvents by cold maceration 
process. Inhibitory activity of aqueous extracts of Mimosa pudica 
plants were investigated by agar disc well diffusion method against 
bacterial pathogens Staphylococcus aureus, Bacillus subtilus, 
Escherichia Coli, K. Pneumonia, M. luteus and C. Albicans and the 
result showed good antimicrobial activity (28 mm) in E. Coli at 
100% concentration of sample, in others it was found more or less 
similar to our present investigation. So the data indicated that gram 
negative was the sensitive strain, CHL from Mimosa pudica have 
been effectively proven for their utilization as a source for 
antimicrobial compound [20]. 
The natural Chlorophyllin from Mimosa pudica has potential 
antimicrobial activity, and it may be useful for the development of 
pharmaceutical industries as a therapy against various diseases. 
Further studies required to understand the mechanism and the 
actual efficacy of the chlorophyllin.  
ACKNOWLEDGEMENT 
We thank Dr. Ishari. K. Ganesh, Chancellor, Vels University, Chennai, 
TamilNadu, India for providing all the facilities throughout the 
research work. 
CONFLICT OF INTERESTS  
Conflict of interest declared none 
REFERENCES 
1. Sala AV. Indian medicinal plants: a compendium of 500 species. 
Chennai: Orient Longman Limited; 1998. p. 36. 
2. Yadava RN, Agrawal PK. A new flavonoid glycoside: 5,7,4ʹ-
trihydroxy-6,3ʹ,5ʹ-trimethoxy-flavone7-O-alpha-
Larabinopyranosyl(1→6)-O-beta-D-glucopyranoside from the 
roots of Mimosa rubicaulis. J Asian Nat Prod Res 1998;1:15-9. 
3. Kirtikar KR, Basu BD. Indian medicinal plants. Dehradun: 
International Book Distributors: 1935. p. 915-7. 
4. Hafsa Ahmad, Sakshi Sehgal, Anurag Mishra, Rajiv Gupta. 
Mimosa pudica L. (Laajvanti): an overview. Pharmacogn Rev 
2012;6:115-24. 
5. Genest S, Kerr C, Shah A, Rahman MM, Saif-E-Naser GM, Nigam 
P, et al. Comparative bioactivity of two Mimosa species. Lat Am 
Caribb Bull Med Aromat Plants 2008;7:38-43. 
6. Egner PA, Munoz, Kensler TW. Chemoprevention with 
chlorophyllin in individuals exposed to dietary aflatoxin. 
Mutation Res 2003;524:209-16. 
7. Rajalakshmi K, Banu N. Antioxidant capacity of chlorophyllin 
from Mimosa pudica by the formation of a phospho- 
molybdenum complex. Int J Front Sci Technol 2014;2:7-14. 
8. Schertz FM. The extraction and separation of Chlorophyll (α+β) 
carotene and xanthophyll in fresh green leaves preliminary to 
their quantitative determination. Plant Physiol 1928;3:211–6. 
9. Holder IA, Boyce ST. Agar well diffusion assay testing of 
bacterial susceptibility to various antimicrobials in 
concentrations non-toxic for human cells in culture. Burns 
1994;20:426-9. 
10. Tona L, Kambu K, Ngimbi N, Cimanga K, Vlietinck AJ. 
Antiamoebic and phytochemical Spina-Christi sterm bark in 
rats. Acta Trop 1998;6:1-5.  
11. Samy RP, Ignacimuthu S. Antibacterial activity of some folklore 
medicinal plants used by tribals in the Western Ghats in India. J 
Ethnopharmacol 2000;69:63-71. 
12. Palombo EA, Semple SJ. Antibacterial activity of traditional 
medicinal plants. J Ethnopharmacol 2001;77:151-7. 
13. Kumaraswamy Y, Cox PJ, Jaspars M, Nahar L, Sarker S. 
Screening seeds of Scottish plants for antibacterial activity. J 
Ethnopharmacol 2002;83:73-7. 
14. Stepanovic S, Antic N, Dakic I, Svabic-vlahovic M. In vitro 
antimicrobial activity of propilis and antimicrobial drugs. 
Microbiol Res 2003;158:353-7.  
Rajalakshmi et al. 
Int J Pharm Pharm Sci, Vol 8, Issue 4, 387-389 
389 
15. Ojalla T, Remes S, Hans P. Antimicrobial activity of some 
coumarin-containing herbal plants growing in Finland. J 
Ethnopharmacol 1999;68:267-74. 
16. Ahmad I, Beg AZ. Antimicrobial and phytochemical studies on 
45 Indian medicinal plants against multi-drug resistant human 
pathogens. J Ethnopharmacol 2001;74:113–23.  
17. John A, Alberti KG, Zimmet PZ, Parrotta. Healing plants of 
peninsular India, CABI publishing USA, 557(2001). Diabetic Med 
1998;15:539-53. 
18. Lubna Azmi, Manish Kumar Singh, Ali Kamal Akhtar. 
Pharmacological and biological overview on Mimosa pudica 
Linn. Int J Pharm Life Sci 2011;2:1226-34. 
19. Pawaskar SM, Kale KU. Antibacterial activity of successive 
extracts of Mimosa pudica. Indian Drugs 2006;43:476-80. 
20. Mukesh Chandra Sharma, Smita Sharma. Phytochemical and 
pharmacological screening of combined Mimosa pudica Linn 
and Tridax procumbens for in vitro antimicrobial activity. Int J 
Microbiol Res 2010;1:171-4.  
 
